Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypass
- 1 February 2002
- journal article
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 16 (1) , 59-63
- https://doi.org/10.1053/jcan.2002.29677
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Consequences of Tissue Factor Pathway Inhibitor Gene-Disruption in MiceThrombosis and Haemostasis, 1997
- The present status of tissue factor pathway inhibitorBlood Coagulation & Fibrinolysis, 1992
- Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant.Proceedings of the National Academy of Sciences, 1991
- Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitorBlood, 1988
- Modifications of Extrinsic Pathway Inhibitor (EPI) and Factor Xa that Affect their Ability to Interact and to Inhibit Factor Vila/Tissue Factor: Evidence for a Two-Step Model of InhibitionThrombosis and Haemostasis, 1988
- Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)Thrombosis Research, 1988
- The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of actionBlood, 1988
- Inhibition of the tissue factor-factor vii complex: involvement of factor xa and lipoproteinsThrombosis Research, 1987
- Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulationBlood, 1987
- Characterization of the inhibition of tissue factor in serumBlood, 1987